Thursday, May 11, 2023 10:54:15 PM
I would suspect that the chance may be good that the Dr. who does the surgery may also be the one who's routinely treating the patient. If a hospital setting isn't necessary at all, such Drs. generally have offices, some within the hospitals, some elsewhere, but my point is they're not just surgeon, they're also the patients oncologist.
I can't speak for other institutions, but I would suspect that if City of Hope were doing the surgery and treating the patient they would have an employee escort the products being made into the vaccine to where it was to be manufactured, and return to bring the vaccine back to City of Hope to be administered. That's how they treat stem cells, and in that there are similarities here where improper handling at any point could result in a failure, I would suspect they'd want as much control as they could have.
I cannot say if others handle things the way City of Hope does, but I suspect that as long as they're paid for such handling they'd prefer to do that over having a contractor do it.
Many years ago we dealt with cryogenically fitted pipe fittings, they were shipped all over the world in vacuum flasks and the few times we used them their was no problem. As the fitting warmed it shrunk and created a very strong seal on whatever it was joining. Though this was very successful when we tried it, if there had been a problem, you could simply ship the fitting that warmed up prematurely back to the manufacture where they could be re-expanded under cryogenic conditions, and reused. No such opportunity exists if either patient products are spoiled while being transported to make the vaccine, or the vaccine spoils while being transported to where it will be used. The treatment option may be completely lost unless excess material exists for making an additional batch.
Gary
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM